Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Brain : a journal of neurology

• Publication date

  2003-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/BRAIN/AWG223PMID 12821509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myasthenia gravis, thymectomy, and antiacetylcholine receptor antibody

  2004cited by this paper
• [Seronegative myasthenia gravis].

  2004cited by this paper
• Clinical aspects of MuSK antibody positive seronegative MG

  2003influential reference
• Treatment of refractory myasthenia: “Rebooting” with high‐dose cyclophosphamide

  2003cited by this paper
• Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.

  2003influential reference
• AChR phosphorylation and indirect inhibition of AChR function in seronegative MG

  2002cited by this paper
• The agrin/muscle‐specific kinase pathway: New targets for autoimmune and genetic disorders at the neuromuscular junction

  2002cited by this paper
• Building the vertebrate neuromuscular synapse.

  2002cited by this paper
• Anti-P110 Autoantibodies Identify a Subtype of “Seronegative” Myasthenia Gravis with Prominent Oculobulbar Involvement

  2002influential reference
• Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

  2001cited by this paper
• Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.

  2000cited by this paper
• The juxtamembrane region of MuSK has a critical role in agrin‐mediated signaling

  2000cited by this paper
• Myasthenia gravis

  2000influential reference
• Distinct Domains of Musk Mediate Its Abilities to Induce and to Associate with Postsynaptic Specializations

  1999cited by this paper
• A Treatment Algorithm for Autoimmune Myasthenia in Adults

  1998cited by this paper
• Purified IgG from seropositive and seronegative patients with myasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels

  1998cited by this paper
• Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold.

  1997cited by this paper
• The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo.

  1996cited by this paper
• Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects.

  1996cited by this paper
• Biotinylation of cell surface MHC molecules: a complementary tool for the study of MHC class II polymorphism in cattle.

  1996cited by this paper
• Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury.

  1995cited by this paper
• Familial autoimmune myasthenia gravis: report of four families.

  1995cited by this paper
• Passive transfer of seronegative myasthenia gravis to mice

  1994cited by this paper
• Familial autoimmune myasthenia gravis

  1994cited by this paper
• Clinical heterogeneity of seronegative myasthenia gravis.

  1994influential reference
• Electrophysiological Characteristics in Seronegative Myasthenia Gravis a

  1993cited by this paper
• Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor Function a

  1993cited by this paper
• Seronegative generalized myasthenia gravis

  1992cited by this paper
• Seronegative myasthenia gravis: clinical features, response to therapy and synthesis of acetylcholine receptor antibodies in vitro.

  1991influential reference
• Agrin induces phosphorylation of the nicotinic acetylcholine receptor.

  1991cited by this paper
• Seronegative myasthenia gravis

  1988cited by this paper
• Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.

  1986cited by this paper
• An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis.

  1977cited by this paper

• Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data

  2025cites this paper
• Management of Myasthenic Crisis and Emerging Roles of Molecularly Targeted Therapies: A Narrative Review

  2025cites this paper
• Clinical Features and Outcome in Myasthenia Gravis Patients with Antimuscle-specific Tyrosine Kinase Antibody: A Retrospective Study.

  2025cites this paper
• The clinical evaluation of myasthenia gravis.

  2025cites this paper
• MuSK-myasthenia gravis in a patient with overlap syndrome — Bickerstaff encephalitis and pharyngo-cervico-brachial variant of Guillain-Barré syndrome

  2025cites this paper
• Selective Degradation of Pathogenic Autoantibodies by Lysosomal Targeting Chimeras for the Treatment of Myasthenia Gravis

  2025cites this paper
• Autoantibodies in myasthenia gravis.

  2025cites this paper
• Serum from patients with MuSK antibody-positive myasthenia gravis triggers transcriptomic changes leading to muscle atrophy and weakness in human myotube cells.

  2025cites this paper
• Typical and atypical clinical presentations.

  2025cites this paper
• Comprehensive Analysis of Uric Acid and Myasthenia Gravis: IGF1R as a Protective Factor and Potential Therapeutic Target

  2025cites this paper
• 275th ENMC international workshop: Seronegative myasthenia gravis: An update paradigm for diagnosis and management, 9-11 February 2024, Hoofddorp, the Netherlands.

  2024cites this paper
• Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models

  2024cites this paper
• MuSK Antibody Positive Myasthenia Gravis Mimicking as Myositis

  2024cites this paper
• A Case Report of MuSK Antibody-Positive Myasthenia Gravis

  2024cites this paper
• The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology

  2024cites this paper
• Isolated Respiratory Failure as the Presenting Symptom of Muscle-Specific Kinase Myasthenia Gravis: A Case Report and Literature Review

  2024cites this paper
• The role of thymectomy in the treatment of myasthenia

  2024cites this paper
• Maternal Myasthenia Gravis: A Case Report

  2024cites this paper
• Acetylcholinesterase inhibitors are ineffective in MuSK-antibody positive myasthenia gravis: Results of a study on 202 patients.

  2024cites this paper
• Case report: Rapid clinical improvement in acute exacerbation of MuSK-MG with efgartigimod

  2024cites this paper
• A clinical perspective on muscle specific kinase antibody positive myasthenia gravis

  2024cites this paper
• The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatment

  2024cites this paper
• Muscle-specific Tyrosine Kinase Antibody-positive Myasthenia Gravis Unmasked by Fluoroquinolone: A Case Report

  2024cites this paper
• Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation

  2024cites this paper
• Efgartigimod Successfully Ameliorated Acute Exacerbation of Myasthenia Gravis with Anti-muscle-specific Kinase Antibodies

  2024cites this paper
• Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China

  2024cites this paper
• Pregnancy in MuSK‐positive myasthenia gravis: A single‐center case series

  2023cites this paper
• New diagnosis of myasthenia gravis in the third trimester - A case report.

  2023cites this paper
• IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein

  2023cites this paper
• Global research hotspots and frontiers of myasthenia gravis from 2002 to 2021: A bibliometric study

  2023cites this paper
• Triple-seronegative myasthenia gravis: clinical and epidemiological characteristics

  2023influential citation
• Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review

  2023cites this paper
• IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation

  2023cites this paper
• Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease

  2023cites this paper
• Bibrachial amyotrophy as a rare manifestation of intraspinal fluid collection: a case report and systematic review

  2023cites this paper
• Myasthenia research over the last 50 years – a personal perspective

  2023cites this paper
• Electrophysiological evaluation of the neuromuscular junction: a brief review

  2023cites this paper
• Morbidity analysis of verified cases of myasthenia gravis in central Kazakhstan

  2023cites this paper
• Amyotrophic lateral sclerosis mimics

  2022cites this paper
• Is paravertebral muscles edema a consequence of neurogenic changes in MuSK-positive myasthenia gravis?

  2022cites this paper
• Comprehensive evaluation of velopharyngeal function in myasthenia gravis patients

  2022cites this paper
• The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study.

  2022cites this paper
• MicroRNA expression profiles of peripheral blood and mononuclear cells in myasthenia gravis: A systematic review.

  2022cites this paper
• Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis

  2022cites this paper
• Neurophysiological challenges in myasthenia gravis associated with MuSK antibodies: a case report

  2022cites this paper
• Factors affecting minimal manifestation status induction in myasthenia gravis

  2022cites this paper
• Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients

  2022cites this paper
• Amino acids levels as a potential biomarker in myasthenia gravis.

  2022influential citation
• Major advances in neuromuscular disorders in the past two decades.

  2022cites this paper
• Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals

  2022cites this paper
• Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies

  2022cites this paper
• The role of Serum Free Light Chain as Biomarker of Myasthenia Gravis.

  2022cites this paper
• Outcomes and characteristics of myasthenia gravis: A 10-year retrospective cross-sectional study at King Fahad Medical City

  2022cites this paper
• Anti-MuSK myasthenia after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

  2022cites this paper
• Iranian Consensus Recommendations for Treatment of Myasthenia Gravis.

  2022cites this paper
• Bedside and laboratory diagnostic testing in myasthenia

  2022cites this paper
• Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study

  2022cites this paper
• Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective

  2022cites this paper
• Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders

  2021cites this paper
• Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New

  2021cites this paper
• MuSK Myasthenia Gravis Presenting with Bilateral Vocal Cord Abduction Paresis

  2021cites this paper
• Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study.

  2021cites this paper
• Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis

  2021cites this paper
• Acute Respiratory Failure in Neuromuscular Disorders

  2021cites this paper
• Accuracy of patient-reported data for an online patient registry of autoimmune myasthenia gravis and Lambert-Eaton myasthenic syndrome.

  2021cites this paper
• MuSK+ Myasthenia Gravis Presenting with Severe Sleep Apnea, Respiratory Dysfunction and Response to Rituximab

  2021cites this paper
• A case of MuSK antibody‐positive myasthenia gravis patient mimicking amyotrophic lateral sclerosis with four videofluoroscopic examinations

  2021cites this paper
• Advances in treating myasthenia gravis

  2021cites this paper
• MuSK Antibody–Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report

  2021cites this paper
• [Myasthenia gravis and muscle atrophy].

  2021cites this paper
• Neuromuscular Complications of General Medical Disorders

  2021cites this paper
• Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody–Positive Generalized Myasthenia Gravis

  2021cites this paper
• IgG4-Mediated Neurologic Autoimmunities

  2021cites this paper
• Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis: A Neuromuscular Surprise

  2021cites this paper
• Assessment of Sarcopenia and Obesity in Patients with Myasthenia Gravis Using Dual-Energy X-ray Absorptiometry: A Cross-Sectional Study

  2021cites this paper
• Utilidad de los anticuerpos en las enfermedades de la unión neuromuscular: revisión

  2021cites this paper
• Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomes

  2021cites this paper
• Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study

  2021cites this paper
• Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis

  2021cites this paper
• A 52-Year-Old Female Presenting with Dysphagia

  2021cites this paper
• Neuro-Ophthalmology Approach to Oculoplastic Disorders

  2020cites this paper
• Immune Checkpoint Inhibitor-Induced Myasthenia Gravis

  2020cites this paper
• Subgroup stratification and outcome in recently diagnosed generalized myasthenia gravis

  2020cites this paper
• Pediatric Ocular Myasthenia Gravis: A Review

  2020cites this paper
• Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology

  2020cites this paper
• Silent microaspirations: The forerunner to the diagnosis of bulbar onset myasthenia gravis in a young woman.

  2020cites this paper
• MuSK antibodies, lessons learned from poly- and monoclonality.

  2020cites this paper
• High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravis

  2020cites this paper
• AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review.

  2020cites this paper
• ANTIBODIES AND RECEPTORS: from neuromuscular junction to central nervous system.

  2020cites this paper
• MuSK EAMG: Immunological Characterization and Suppression by Induction of Oral Tolerance

  2020cites this paper
• Clinical and therapeutic features of myasthenia gravis in adults based on age at onset.

  2020cites this paper
• Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics

  2020cites this paper
• Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of myasthenia-myositis association from a large cohort of patients.

  2020cites this paper
• Inflammation and apoptosis accelerate progression to irreversible atrophy in denervated intrinsic muscles of the hand compared with biceps: proteomic analysis of a rat model of obstetric brachial plexus palsy

  2020cites this paper
• THE ROLE OF ACALYPHA INDICA LINN EXTRACT ON EXPRESSION OF ACETYLCHOLINE RECEPTOR IN NEUROMUSCULAR JUNCTIONS WITH MYASTHENIA GRAVIS RAT MODEL

  2020cites this paper
• A challenging case of hypercapnic respiratory failure during pregnancy

  2020cites this paper
• Differential response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study.

  2020cites this paper
• Muscle-Specific Kinase Myasthenia Gravis

  2020cites this paper
• Myasthenia Gravis: Do the Subtypes Matter?

  2020cites this paper